Nanoparticle Albumin Bound Paclitaxel in the Third-Line Treatment of Recurrent Small Cell Lung Cancer in Real-World Practice: A Single Center Experience
Conclusions: As a single-agent third-line treatment for patients with relapsed SCLC, Nab-P was effective and safe.PMID:34657492 | DOI:10.1177/15330338211050775
Source: Technology in Cancer Research and Treatment - Category: Cancer & Oncology Authors: Yuchao Wang Li Li Chunhua Xu Source Type: research
More News: Abraxane | Anemia | Cancer | Cancer & Oncology | Chemotherapy | Gastroenterology | Lung Cancer | Nanotechnology | Small Cell Lung Cancer | Study | Thrombocytopenia